杭州安杰思医学科技股份有限公司股东减持股份计划公告

Group 1 - The core point of the announcement is that shareholders of Hangzhou Anjisi Medical Technology Co., Ltd. plan to reduce their holdings in the company, with specific details on the number of shares and methods of reduction [1][2][3] - Shareholder Suzhou Yuansheng Private Fund Management Partnership intends to reduce up to 1,622,700 shares, accounting for 2.0039% of the total shares, through both centralized bidding and block trading [2][3] - Shareholder Hangzhou Paradise Silicon Valley Venture Capital Management Co., Ltd. also plans to reduce up to 1,622,700 shares, with the same percentage and methods as mentioned above [2][3] Group 2 - The reduction period for shares through centralized bidding will be within 90 natural days after 15 trading days from the announcement date, while block trading will commence 3 trading days after the announcement [2][3] - The announcement specifies that if there are any changes in the company's capital structure, such as stock dividends or capital increases, the number of shares to be reduced will be adjusted accordingly [2][3] - The shareholders have confirmed that they have no consensus on the reduction plan and have made prior commitments regarding their shareholding [3][4]